Finance

Beta
Lists
MDNA:TSE
Medicenna Therapeutics Corp
CA$0.43
-3.37%
(-0.015) 1D
May 21, 2:40:08 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for MDNA...
Open
CA$0.44
High
CA$0.46
Low
CA$0.42
Mkt. cap
35.47M
Avg. vol.
139.99K
Volume
78.23K
52-wk high
CA$1.97
52-wk low
CA$0.42
EPS
-CA$0.16
Beta
1.65
Shares outstanding
83.42M
No. of employees
18
News stories
From sources across the web
About Medicenna Therapeutics Corp
CEO-
Employees18
Founded2015
HeadquartersToronto, Ontario, Canada
SectorBiotechnology
Websitemedicenna.com
Last report
Nov 4, 2022
Fiscal period
Q2 2023
EPS / Est. (CAD)
-CA$0.07 / -CA$0.07
-7.84%miss
Revenue / Est. (CAD)
- / 0.00
Fiscal Q2 2023 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.49M
4.21M
4.11M
4.07M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.22M
1.30M
1.36M
1.54M
Operating expense
5.72M
5.51M
5.47M
5.62M
Total operating expenses
5.72M
5.51M
5.47M
5.62M
Operating income
-5.72M
-5.51M
-5.47M
-5.62M
Other non operating income
6.75M
1.28M
200.00K
1.29M
EBT including unusual items
1.19M
-4.93M
-4.88M
-4.36M
EBT excluding unusual items
1.19M
-4.93M
-4.88M
-4.36M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
1.19M
-4.93M
-4.88M
-4.36M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
264.00K
204.00K
158.00K
114.00K
Interest expense
-
-
-
-
Net interest expenses
264.00K
204.00K
158.00K
114.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.71M
-5.49M
-5.46M
-5.61M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer